InsidersTradesSigma
Follow the 健之佳 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 健之佳 has recorded 13 reports. Market capitalisation: €2.4bn. The latest transaction was reported on 25 September 2025 (Purchase). Among the most active insiders: 蓝心悦. Every trade is free.
13
Insider Decl.
n/a
Thresholds
€452,554
13 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,181 of 28,803 companies
62.3
score / 100
Value85
Quality40
FCF yld42%
Earn yld6.1%
EV/EBITDA5.9x
ROE5.5%
Gross mgn36%
Net mgn1.7%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 September 2025
Declarations13 total
13 of 13 declarations
About 健之佳
健之佳 is a company operating in the health and pharmaceutical sector, listed on the XSHG market. It focuses on the development and distribution of pharmaceutical and healthcare products.